Joseph W. Venslavsky
GlaxoSmithKline (United Kingdom)(GB)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase(2008)155 cited
- → Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake(1985)130 cited
- → Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic(1999)116 cited
- → Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists(1996)72 cited
- → Conformational Preferences in a Benzodiazepine Series of Potent Nonpeptide Fibrinogen Receptor Antagonists(1999)53 cited
- → New Benzylidenethiazolidinediones as Antibacterial Agents(2003)50 cited
- → Antiparasitic agents. 6. Synthesis and anthelmintic activities of novel isothiocyanatophenyl-1,2,4-oxadiazoles(1985)44 cited
- → ChemInform Abstract: ORALLY ACTIVE AND POTENT INHIBITORS OF Γ‐AMINOBUTYRIC ACID UPTAKE(1985)37 cited
- → Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist(1994)28 cited
- → Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins(1986)26 cited